Фильтр

Фармацевтическая промышленность в России: инвестиции, проекты, холдинги

Подотрасли: Лекарственные препараты - 176 (······ ········), Медицинские изделия - 82 (········ ········)
Регионы: Московская область - 45 (···· ········), Калужская область - 12 (········ ········), Санкт-Петербург - 22 (········ ········), Кировская область - 8 (········ ········), Москва - 25 (········ ········), Татарстан - 3 (········ ········), Рязанская область - 4 (···· ········), Нижегородская область - 3 (········ ········), Брянская область - 3 (········ ········) , Новосибирская область - 8 (········ ········), Мордовия - 7 (········ ········), Белгородская область - 7 (········ ········), Краснодарский край - 5 (········ ········), Тюменская область - 3 (········ ········), Башкортостан - 7 (········ ········), Курганская область - 2 (·· ········), Курская область - 4 (········ ········), Астраханская область - 2 (······ ········), Ленинградская область - 3 (······ ········), Ярославская область - 2 (········ ········), Пермский край - 4 (········ ········), Тверская область - 2 (········ ········), Тульская область - 4 (········ ········), Орловская область - 2 (········ ········), Смоленская область - 1 (·· ········), Чувашская Республика - 1 (·· ········), Иркутская область - 2 (········ ········), Липецкая область - 1 (······ ········), Псковская область - 2 (········ ········), Алтай - 1 (······ ········), Свердловская область - 4 (········ ········), Северная Осетия - Алания - 1 (·· ········), Ульяновская область - 1 (·· ········), Владимирская область - 3 (······ ······), Приморский край - 2 (······ ······), Челябинская область - 1 (······ ······), Архангельская область - 1 (······ ······), Ростовская область - 1 (······ ······), Самарская область - 2 (······ ······), Костромская область - 1 (······ ······), Томская область - 1 (······ ······), Еврейская автономная область - 1 (······ ······), Воронежская область - 1 (······ ······), Кемеровская область - 1 (······ ······), Саратовская область - 1 (······ ······), Вологодская область - 1 (···· ······) Показать все... Скрыть
Стадии: Приостановлен - 66 (······ ········), Предпроектные проработки - 53 (······ ········), Строительство - 52 (········ ········), Проектирование - 28 (········ ········), Подготовка к строительству - 8 (········ ········), Модернизация - 21 (········ ········)
Страны ЕАЭС: Беларусь - 9 (········ ········), Казахстан - 12 (········ ········), Узбекистан - 10 (········ ········), Кыргызстан - 3 (········ ········), Азербайджан - 3 (········ ········), Китай - 1 (······ ······), Таджикистан - 1 (······ ······)
Период: 2023 - 2034
Холдинги:  148
Проектов всего за 2023-2034гг. (с приостановленными, без введенных в эксплуатацию и отмененных):  258 (533 млрд руб.)
Проектов всего за 2023-2034гг. (без приостановленных, введенных в эксплуатацию, отмененных):  192 (388 млрд руб.)
Проектов, введенных в эксплуатацию за 2013-2023гг.:  395 (456 млрд руб.)
Проектов по фильтру:  258 (533 млрд руб.)

Новости отрасли
  • 03.10.2022

    "Интеррос" миллиардера Потанина продаст 100% производителя вакцин "Петровакс" его менеджменту и VB Partners . Продажа носит технический характер.

    Комментарий: "Петровакс" остается в контуре холдинга "Интеррос".

  • 22.09.2022
    ······················ ······ ························································.········································-······································ ························ ·············· ·················· ························································.········································································ ························ ······················ ·· ·············· ································ ·················· ········ ·· ···································· ·············· ························ ·· ···················· ·················· ···················· ···· ············ ······················ ················ ·· ·················· ·················· ···················· ················ ······················ ·················· ······························ ············ ·············· ···· ························································.········································-········································ ·························· ·· ········ ·················· ············ ····························
  • 01.09.2022
    ········ ················-··················-·················· ························································.···························································································· ·············· ···················· ·········· ········ ·········· ························ ···· ························································.······································································ ·· ························ ·················· ·············· ················ ·············· ·············· ········ ·· ················ ············ ·········· ·········· ················ ·· ·············· ···· ·············· ·· ·············· ········ ········ ······················ ·············· ···· ··········-···· ···························· ················ ···················································· ······ ························································.···································································· ················ ·· ············ ················ ···· ························································.····················································································································
  • 29.08.2022
    ············ ·············· ························ ··········-·············· ··········-················ ············-············ ·············· ········ ········ ·································· ·············· ···· ························································.······································-···························· ······················ ············ ·· ···· ·············· ·············· ······················ ·············· ········ ················ ·········· ······························ ················ ······················ ······ ······································ ············································ ······························ ······················ ···················· ···· ························································.······································-···························· ························ ·· ········ ·················· ················ ········ ······ ················ ································ ·········· ·········· ················ ················
  • 04.02.2022
    ································ ·············· ···· ························································.·································································· ············ ············ ···· ·············· ························ ············ ·········· ···················· ················ ········ ···· ························································.·············································································· ···· ············ ········ ················ ················ ·············· ········ ·································· ························································.················································ ···························· ············ ···· ·········· ············ ················ ········ ·· ············ ·········· ···· ························································.····································-········································ ·· ················ ············ ············ ·············· ···················· ················ ·· ······································ ······························ ···· ························································.············································································ ················ ·· ············ ················ ···· ························································.·································································· ·· ················ ································

  • 2.

    Инвестиции в проекты по годам в отрасли "Фармацевтическая промышленность"

    С приостановленными Без приостановленных
    Все проекты
    Отсортировано по убыванию | все / первые 10

    3.

    Структура инвестиций по холдингам

    С приостановленными Без приостановленных
    Все проекты
    Отсортировано по убыванию | все / первые 10

    4.

    Динамика добавления новых проектов в отрасли "Фармацевтическая промышленность"

    5.

    Реализованные проекты по холдингам в отрасли "Фармацевтическая промышленность"

    Все проекты
    Отсортировано по убыванию | все / первые 10

    6.

    Проекты на активной стадии (без приостановленных) в отрасли "Фармацевтическая промышленность"

    7.

    Динамика ввода в эксплуатацию в отрасли "Фармацевтическая промышленность"

    8.

    Динамика приостановки проектов в отрасли "Фармацевтическая промышленность"

    9.

    Динамика отмены проектов в отрасли "Фармацевтическая промышленность"

    10.

    Структура инвестиций на карте в отрасли "Фармацевтическая промышленность"

    Планирование Предпроект Проектирование Подг. к строительству Строительство Введен в эксплуатацию Модернизация Приостановлен Россия Другие страны
    11.

    Структура инвестиций по стадиям (РФ) в отрасли "Фармацевтическая промышленность"

    Все проекты
    Отсортировано по убыванию | все / первые 10

    12.

    Структура инвестиций по регионам РФ в отрасли "Фармацевтическая промышленность"

    С приостановленными Без приостановленных
    Все проекты
    Отсортировано по убыванию | все / первые 10

    13.

    Структура инвестиций в иностранной собственности в отрасли "Фармацевтическая промышленность"

    С приостановленными Без приостановленных
    Все проекты
    Отсортировано по убыванию | все / первые 10

    Показать